Douglas K. Howell
Thanks, Pat, and hello, everyone. Today, I'll first walk you through our earnings release and provide some brief comments on organic growth and margins by operating segment, and also on our corporate segment results. Next, I'll move to the CFO commentary document we post on our IR website. I'll walk you through our typical modeling helpers and our outlook for '26. Additionally, this is where I'll spend a little more time on organic and margins. Then I'll conclude my prepared remarks with my usual comments on cash, M&A, and capital management. Okay. Let's go to the earnings release, to page three. Brokerage segment fourth quarter organic growth was 5%. That's right in line with the information we provided you at our December IR day. Since then, we've received really positive feedback from the investment community for levelizing for the quarterly noise caused by the timing of large life sales and deferred revenue accounting assumptions. That's a fantastic reflection of our sales culture to post 5% in this quarter and 6% for the year. Flipping to page five of the earnings release to the brokerage segment adjusted EBITDAC table, the top half of the page. We told you in December that our fourth quarter '25 headline margin would not be comparable to fourth quarter '24 because, as the footnote to that table explains, we are no longer earning investment income on funds we were holding to buy Assured Partners, and there would also be a rolling impact of 130 basis points. So the quick math shows levelizing for that gets you to 50 basis points of underlying expansion. Right at the midpoint of our 40 to 60 basis points of expansion we estimated during our December IR day. That's really terrific work by the team. So I'll give you some more information on brokerage margins when I get to page eight of the CFO commentary document, because there's headline noise will happen in the '26 again. Sticking on page five. Fourth quarter risk management segment organic growth was 7%, right in line with our December expectations. That reflects strong new business revenues and excellent client retention. Looking to full year '26, we continue to see organic around 7%. And then when you flip to page six, the risk management adjusted EBITDAC margin of 21.6% was a bit better than our December expectation. And as we look forward, we see full year '26 margins in the 21 to 22% range. So turning to page seven of the earnings release and the corporate segment shortcut table. For the adjusted interest and banking, clean energy and acquisition lines, all were very close to the midpoint of our December expectations. The adjusted corporate line was a couple pennies less than our midpoint estimate partly due to a noncash unrealized FX remeasurement loss and a small tax item. Also, while we adjusted out, we wind down and annuitization of our long ago frozen pension plan. Creates a noncash gap expense here in the fourth quarter and will again in Q1 '26. But those reverse through OCI, so it nets to zero. But more importantly, we hit the market just right and didn't have to inject any cash into the plan. Alright. Let's leave the earnings release and go to the CFO commentary document. Starting on page three, these are typical modeling helpers. Most of the fourth quarter '25 actual numbers were close to what we provided back in December, so there's nothing new here. Looking at '26, as you build your models, please use these helpers. In particular, the estimated impact from FX, and the forecasted depreciation and earn out payable expense. Turning to page four of the CFO commentary document. This page breaks down organic performance by business and it's like what we provided for the first time at our December IR day. This view helps you see four things. First, it removes the quarterly comparability impact caused by the large life sales. And second, removes the comparability income impact caused by revenue estimates. These two items were causing a lot of quarterly noise. But as we've said it as we said in December and you can see here, they are really a no never mind on a full year basis. Third thing this view does is it shows you the quarter seasonality of our business. And four, that gives you organic growth another level down. In the table. Two callouts in this page. First, in total, our fourth quarter and full year actuals in blue were in line with our IR day thinking as shown in the gray column. Second, when you move to the pinkish column, we've wrapped up our full year '26 organic budgeting, and our outlook is unchanged. We continue to see '26 brokerage segment organic growth of around 5.5%. That would be another fantastic year. So when you turn to page five in the corporate segment, just two small items. Our full year '26 estimate is unchanged from six weeks ago. And we're now providing a first look at our quarterly estimates. That said, we do have a little more work to do on the corporate segment quarterly budget but full year is done. So maybe a tweak here or there between quarters, and we'll update you during our March IR day. Turning to page six, the investment income table. Three comments here. First, our '26 forecast reflect current FX rates and changes in fiduciary cash balances. Second, our forward estimates continue to assume two future 25 basis point rate cuts over the course of the year, one in April and another in September. Third, the second line of this table shows you the amount of interest income we earned on funds that we are holding to buy AP. Clearly, that has gone away, and you can see it won't repeat here in '26. More on the impact of this on our headline margins when I get to page eight. Staying on page six, but shifting down to the page to the rollover revenue table. The fourth quarter '25 column subtotal of $145 million for brokerage came in pretty close to our December estimate. Looking forward, the pinkish columns to the right include estimated '26 revenues for brokerage M&A closed through yesterday, but you'll see that clearly excludes Assured Partners. We provide a separate page on page seven for Assured Partners. And finally, you'll see the same info for our risk management segment below that. And then to this, you must make your picks for what you think might be unknown M&A that hasn't closed yet throughout 2026. Moving to page seven, this is the same page that we have provided several times before. It shows you how we view AP. Both now it includes third and fourth quarter '20 results and our full year '26 outlook. A few comments here. AP's fourth quarter revenues were in line with our expectations. For the fourth quarter, while expenses came in a little better than expected. Some of that is a little timing between now and throughout '26. Next, the second item, there could be some small refinements in the '26 numbers because we're still a week or so away from having AP budgets locked down. That said, we don't expect anything significant and, of course, we'll update you in the March IR day. Third, be careful when rolling an AP into your '26 models. You can use first and second quarter columns as is, but for third and fourth quarter, it is the delta between the pink numbers and the blue numbers. Fourth, I'll also ask you to closely read the footnote. You're gonna read three things in there. This table reflects the midpoint of our estimates and does not include any revenue or expense synergies. The noncash figures shown on this page, which reflect depreciation and earn out payable, are included within our estimates on page three, so don't double count there. And finally, you'll read that we still see annualized run rate synergies of $160 million by the '26 and then up to $260 to $280 million by early '28. I'm also more and more comfortable there could be upside to these numbers. But give us a little more time before we update our estimates. So this is a page of really, really good news. Moving on to page eight. This is a new page to help you better understand items that impact the comparability of our brokerage segment adjusted EBITDAC margins. In the past, I've done a bridge in my verbal comments to get you past the noise from the impact of FX, changes in interest income, income from cash we're holding on Assured Partners, and then when M&A, that naturally runs lower margins rolls into our numbers. We think these tables paint a better picture than all the words we're using before. Hopefully, this will be more helpful when you build your '26 models. Since this is the first time we've provided this page, let me make a few comments. First, the upper blue table. The punch line is we improved fourth quarter by about 50 basis points. That's all due to the incredibly hard work by the team to control our costs. The lower table gets you started on modeling '26. Blue section first level sets '25 by removing the investment income on funds, we were holding to buy Assured Partners. And also resets for estimated FX at current rates. FX will likely change, but at least it gets you something as of today. The pink section of this table has ranges and margin impact commentary from what we see today. The punch line is nothing has changed since our December IR day, we still see underlying margins expanding 40 to 60 basis points in '26. And we will also begin to benefit from synergies by being better together with AP. You'll also see that we've added a line called unknown M&A with no estimate provided. This is more of a placeholder for you to just think about other factors that could impact margin comparability. Alright. Let's go to page nine to our tax credit carry forward page. At December 31, we had $73.013 billion of tax credit carry forwards. And you'll see in the footnote there that says that we have another billion dollars of future tax benefits related to our purchase of AP. The punch line from this page is the same. It creates a nice cash flow sweetener to fund future M&A. As for some modeling thoughts, when you're modeling cash flows, just assume our cash taxes paid will be about 10% of EBITDAC for the foreseeable future, and that should get you close. Alright. Let's move to cash, capital management, and M&A funding. When I look at available cash on hand, expected free cash flows, and future investment-grade borrowings over the next two years, we might have close to $10 billion to fund M&A before using any stock at attractive multiples. And this was an important point. Well, we talk about our organic a lot. It's worth a reminder that our M&A strategy creates immediate shareholder value through a nice price arbitrage. And it also creates long-term shareholder value through additional sales talent, niche expertise, and further scale. So those are my comments. An excellent '25 for our combined brokerage and risk management segments. Organic growth of 6%, more than $3.5 billion of estimated acquired revenues, adjusted EBITDA growth of 26%, adjusted EBITDAC margin of 35%, up 70 basis points this year on an underlying comparable basis. Now it might be worth a reminder that since COVID hit us, every year our margins have marched higher. We're up over 400 basis points since then. And we still see many more opportunities to improve. Those are fantastic results. So we're on to '26. We have unstoppable momentum driven by an amazing culture. I see '26 being another terrific year. Okay. Back to you, Pat.